Concept Architecture
Concept
Theoretically, the Kaplan-Meier Estimator is a non-parametric estimator of the survival function that estimates the probability of surviving beyond successive time points while accounting for right-censored observations. Developed by Kaplan and Meier in 1958, it is based on the product-limit principle and does not require assumptions regarding the underlying survival distribution. In health economics, the Kaplan-Meier estimator provides the empirical survival estimates that underpin survival analyses, cost-effectiveness models and health technology assessments.
Mathematically, the Kaplan-Meier estimator calculates survival as the cumulative product of conditional survival probabilities at each observed event time. The estimator produces a stepwise survival function that changes only when an event occurs, while censored observations reduce the number at risk without directly affecting the estimated survival probability. Under independent censoring, the estimator is a consistent estimate of the true survival function.
In practice, the Kaplan-Meier estimator is applied to patient-level time-to-event data using statistical software. It is routinely used to estimate overall survival, progression-free survival and disease-free survival, compare treatment groups, estimate median survival and provide the empirical benchmark for selecting and validating parametric survival models used in health economic evaluation.
Purpose
Used to estimate empirical survival probabilities from censored time-to-event data, compare treatment groups and provide the foundation for survival modelling in health economic evaluation.
Mathematical Formulae
Primary Formula
?(t) = ???�? (1 ? d? / n?)
where:
- ?(t) = estimated survival probability
- d? = number of events at time t?
- n? = number at risk immediately before time t?
Supporting Formulae
Conditional survival probability:
p? = 1 ? d? / n?
Median survival:
?(t?.?) � 0.5
Related Mathematical Methods
- Kaplan-Meier curve
- Log-rank test
- Cox proportional hazards model
- Nelson-Aalen estimator
- Fleming-Harrington estimator
- Parametric survival modelling
- Survival analysis
Example
A clinical trial follows 500 patients receiving two cancer treatments. At each observed death, the conditional survival probability is calculated and multiplied by the previous survival estimate. The resulting Kaplan-Meier estimator shows that estimated five-year survival is 68% in the intervention group compared with 55% in the comparator group. These empirical estimates are subsequently used to evaluate candidate parametric survival models for long-term extrapolation.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| IF | =1-(C2/B2) | Calculate conditional survival probability at each event time. |
| PRODUCT | =PRODUCT(E$2:E2) | Calculate cumulative Kaplan-Meier survival estimates. |
| COUNTIFS | =COUNTIFS(TimeRange,">="&A2) | Calculate the number of patients at risk before each event time. |
| MATCH | =MATCH(0.5,F2:F100,-1) | Identify the approximate median survival time from the estimated survival function. |
VBA (Optional)
Automate calculation of Kaplan-Meier survival estimates, update survival tables and generate publication-ready survival summaries.
Sources
- Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations.
- Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data.
- Collett D. Modelling Survival Data in Medical Research.
- Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation.
- NICE. Health Technology Evaluation Manual.
Related Concepts (2)
Library
Tools & Resources
1
survHE — Survival Analysis for Health Economic Evaluation (R package) — Gianluca Baio, R package ed., 2023 (CRAN)
An R package for fitting and comparing parametric survival models for health economic evaluation, including Bayesian estimation, and for extrapolating time-to-event data to inform cost-effectiveness models.
Software (R package)View source →
Frequently Asked Questions (6)
What is the Kaplan-Meier estimator?
A non-parametric method for estimating the survival function from censored data, calculated as the product of conditional survival probabilities at each event.
Source: Kaplan & Meier 1958
Who developed the Kaplan-Meier estimator?
The estimator is named after Edward Kaplan and Paul Meier, who published it jointly in 1958 after independently arriving at similar approaches. Their method estimates survival from data in which some patients are censored, by multiplying together the conditional probabilities of surviving each successive event time. It became the standard non-parametric way to summarise time-to-event data and remains among the most cited methods in medicine. Kaplan and Meier (1958) set it out.
Source: Kaplan & Meier 1958
How is the Kaplan-Meier estimator calculated?
The Kaplan-Meier estimator is calculated by, at each event time, computing the conditional probability of surviving that time as one minus the number of events divided by the number at risk just before it, then multiplying these conditional survival probabilities across all event times up to a given point. Censored individuals reduce the number at risk but do not count as events. This product-limit calculation yields the estimated survival probability over time, stepping down at each event, using both observed events and censored follow-up.
Source: Kaplan & Meier 1958
How does the Kaplan-Meier estimator handle censoring?
The Kaplan-Meier estimator handles censoring by keeping censored individuals in the risk set until their censoring time, so they contribute to the number at risk for events occurring before then, and then removing them without counting an event. This uses their partial follow-up: they inform survival up to censoring but do not bias it downward as if they had the event. Under the assumption that censoring is non-informative, this treatment gives an unbiased estimate of survival despite incomplete follow-up.
Source: Kalbfleisch & Prentice 2002
What are the advantages of the Kaplan-Meier estimator?
The Kaplan-Meier estimator's main advantage is that it makes no assumption about the form of the survival distribution, estimating survival directly from the data, so it is robust and widely applicable. It handles censoring appropriately, is simple to compute and interpret, and provides a clear step-function survival curve. Its non-parametric nature makes it the standard descriptive method for survival data, giving an honest picture of the observed survival without imposing a particular distribution.
Source: Kaplan & Meier 1958
What are the limitations of the Kaplan-Meier estimator?
The Kaplan-Meier estimator becomes unreliable at later times where few remain at risk, giving large, uncertain steps, and it cannot extrapolate beyond the observed follow-up, so it does not estimate long-term survival. Being non-parametric, it does not model covariate effects, for which regression is needed, nor provide a smooth hazard. It also assumes non-informative censoring, which may not hold. These limitations mean it is used for describing observed survival, complemented by regression and parametric models for covariates and extrapolation.
Source: Collett 2015
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 21 Oct 2025
Content version: 1.0.0
Canonical Identity
- Term code
- HE-EM-SM-038
Stable URI · Machine-readable · Resolvable · CC BY 4.0